Shanghai Ixcell Biotechnology Co., Ltd
Clinical trials sponsored by Shanghai Ixcell Biotechnology Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Cord blood stem cells aim to restore movement in stroke survivors Results expected Jun 2027 (estimated)